CNE1000043J1
CNE1000043J1
SANSURE BIOTECH INC
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 9.79B EUR | 8.34B EUR | 10.46B EUR | 10.96B EUR |
Enterprise Value | 7.45B EUR | 6.15B EUR | 7.87B EUR | 8.12B EUR |
Valuation Multiples | ||||
Trailing P/E | 74x | 78.98x | 81.53x | 64.32x |
Forward P/E | 21.54x | -- | -- | -- |
Price to Sales | 6.09x | 6.77x | 8.52x | 8.65x |
Price to Book | 1.39x | 1.19x | 1.46x | 1.54x |
EV/Revenue | 4.64x | 4.99x | 6.41x | 6.41x |
EV/EBITDA | 28.51x | 48.42x | 46.12x | 77.5x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -2.53% | -0.65% | -1.52% | -1.65% |